Atlas Trials

Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer

Clinical trial NCT01840306 · COMPLETED

Trial details

NCT number
NCT01840306
Sponsor
Cancer Trials Ireland
Status
COMPLETED
Study type
OBSERVATIONAL
Breast CancerHER2 Positive Breast CancerHER2 Negative Breast Cancer
Start date
2012-10-12
Primary completion
2023-05-24
Enrollment
330

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.